Appointment bookings to receive Nuvaxovid COVID-19 vaccine open: MOH – CNA

Nuvaxovid is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19.

The vaccine was found to be about 90 per cent effective at preventing symptomatic COVID-19 and 100 per cent effective in preventing severe infection in trials.

As of May 12, 92 per cent of Singapores population have completed their primary vaccination series, while 75 per cent have received their booster doses.

With good vaccination coverage and the majority of our total population well-protected, we will be progressively stepping down the number of vaccination centres from end-May 2022, as previously announced on Apr 22, said MOH.

The first tranche of five Joint Testing and Vaccination Centres will open on May 24, as part of efforts to ensure that COVID-19 testing and vaccination services remain accessible to the general public, it added.

"These centres are designed with the ability to scale up operations in the event of an emerging variant of concern in future."

Another five centres will open progressively across the island from end-June.

To enable the medical service providers to better manage vaccine preparation and reduce any unnecessary wastage, the public is strongly encouraged to book an appointment via the National Appointment System before proceeding to the JTVCs, said MOH.

The centres are as follows:

See original here:

Appointment bookings to receive Nuvaxovid COVID-19 vaccine open: MOH - CNA